Melanoma
📧 Sign up to get email alerts when something new happens for Melanoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2024-05-01Clinical Trial Update: A Study to Find the Best Dose of ASP5354 to Show Lymph Nodes in People With Breast Cancer or Melanoma During Surgery [Phase 2]
A Phase 2 study evaluating ASP5354 to visualize sentinel lymph nodes during surgery in breast cancer or melanoma was terminated. Results hav…
-
CLINICAL_TRIALS trial_result · 2024-04-29Clinical Trial Update: A Study of IMM-101 in Combination With Checkpoint Inhibitor Therapy in Advanced Melanoma [Phase 2]
A Phase 2 study evaluating IMM-101 in combination with checkpoint inhibitor therapy for advanced melanoma has completed, with results posted…
-
CLINICAL_TRIALS trial_result · 2024-04-22Clinical Trial Update: Nivolumab Dose Optimization in Patients With a Complete, Partial or Stable Response [Phase 4]
Phase 4 trial updating nivolumab dose optimization in melanoma patients who have complete, partial, or stable response.
-
CLINICAL_TRIALS trial_result · 2024-04-12Clinical Trial Update: Study of PF-07263689 in Participants With Selected Advanced Solid Tumors [Phase 1]
Phase 1 trial of PF-07263689 in selected advanced solid tumors was terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2024-03-18Clinical Trial Update: Study of Dabrafenib+Trametinib in the Adjuvant Treatment of Stage III BRAF V600+ Melanoma After Complete Resection to Evaluate the Impact on Pyrexia Related Outcomes [Phase 3]
Phase 3 trial update evaluating dabrafenib plus trametinib as adjuvant therapy for stage III BRAF V600+ melanoma after complete resection, w…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2024-03-12Clinical Trial Update: Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease. [Phase 1, Phase 2]
A multi-center Phase 1/2a trial evaluating an autologous tumor lysate with yeast cell wall particles and dendritic cells plus standard of ca…
-
CLINICAL_TRIALS trial_result · 2024-03-08Clinical Trial Update: A Safety and Tolerability Study of NC318 in Subjects With Advanced or Metastatic Solid Tumors [Phase 1, Phase 2]
A safety and tolerability study of NC318 in advanced or metastatic solid tumors completed Phase 1/2 with results posted in 2024.
-
CLINICAL_TRIALS trial_result · 2024-03-06Clinical Trial Update: Adaptive Staged Stereotactic Body Radiation Therapy in Treating Patients With Spinal Metastases That Cannot Be Removed by Surgery [NA]
Clinical trial update for adaptive staged stereotactic body radiation therapy in patients with spinal metastases, completed with posted resu…
-
CLINICAL_TRIALS trial_result · 2024-03-05Clinical Trial Update: LGX818 and MEK162 in Combination With a Third Agent (BKM120, LEE011, BGJ398 or INC280) in Advanced BRAF Melanoma [Phase 2]
Phase 2 trial update of LGX818 and MEK162 in combination with a third agent in advanced BRAF-mutant melanoma has completed with posted resul…
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Vaccine Therapy With or Without Interleukin-2 in Treating Patients With Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating vaccine therapy with or without interleukin-2 in metastatic melanoma (stage IV/recurrent) has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: flt3L With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma or Renal Cell Cancer [Phase 2]
Phase 2 trial evaluating flt3L with or without vaccine therapy in patients with metastatic melanoma or renal cell cancer has completed.
-
CLINICAL_TRIALS trial_result · 2024-03-04Clinical Trial Update: Vaccine Therapy in Treating Patients With High-Risk Stage III or Completely Resected Metastatic Melanoma [Phase 2]
Phase 2 trial update for a vaccine therapy in high-risk Stage III or completely resected metastatic melanoma shows completed status.
-
CLINICAL_TRIALS trial_result · 2024-02-28Clinical Trial Update: Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 trial evaluating lifileucel with reduced-dose fludarabine/cyclophosphamide lymphodepletion and interleukin-2 for unresectable or met…
-
CLINICAL_TRIALS trial_result · 2024-02-20Clinical Trial Update: A Study of RC48-ADC in Advanced Melanoma Subjects With HER2 Variant (Mutation, Amplification, Overexpression) [Phase 2]
A Phase 2 clinical trial update for RC48-ADC in advanced melanoma with HER2 variant/mutation/amplification/overexpression is ongoing, with u…
-
CLINICAL_TRIALS trial_result · 2024-02-15Clinical Trial Update: Tiragolumab Plus Atezolizumab Versus Atezolizumab in the Treatment of Stage II Melanoma Patients Who Are ctDNA-positive Following Resection [Phase 2]
A Phase 2 trial comparing tiragolumab plus atezolizumab versus atezolizumab alone in ctDNA-positive Stage II melanoma after resection has be…
-
CLINICAL_TRIALS trial_result · 2024-02-08Clinical Trial Update: A Study Evaluating the Safety and Efficacy of Cobimetinib Plus Atezolizumab in BRAFV600 Wild-type Melanoma With Central Nervous System Metastases and Cobimetinib Plus Atezolizumab and Vemurafenib in BRAFV600 Mutation-positive Melanoma With Central Nervous System Metastases [Phase 2]
Phase 2 trial evaluating cobimetinib in combination with atezolizumab, with/without vemurafenib, for BRAFV600 wild-type and BRAFV600 mutatio…
-
CLINICAL_TRIALS trial_result · 2024-02-06Clinical Trial Update: Vaccination With 6MHP, With or Without Systemic CDX-1127, in Patients With Stage II-IV Melanoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update evaluating Vaccination with 6MHP with or without CDX-1127 in patients with melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-26Clinical Trial Update: The Scandinavian Randomized Controlled Trial of Isolated Hepatic Perfusion for Uveal Melanoma Liver Metastases [Phase 3]
Phase 3 trial update on isolated hepatic perfusion for liver metastases from uveal melanoma has completed.
-
CLINICAL_TRIALS trial_result · 2024-01-23Clinical Trial Update: CHEckpoint Inhibition in Combination With an Immunoboost of External Beam Radiotherapy in Solid Tumors [Phase 2]
Phase 2 trial evaluating checkpoint inhibition in combination with external beam radiotherapy for solid tumors; study is completed.
-
CLINICAL_TRIALS trial_result · 2024-01-18Clinical Trial Update: Study of Efficacy and Safety of Novel Spartalizumab Combinations in Patients With Previously Treated Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 results from a study of spartalizumab combinations in previously treated unresectable or metastatic melanoma have been posted. The t…
-
CLINICAL_TRIALS trial_result · 2024-01-12Clinical Trial Update: Novel Mechanisms and Predictors of VEGF Receptor Inhibitor- or Immune Checkpoint Inhibitor-Associated Hypertension and Cardiovascular Disease
A terminated clinical trial exploring mechanisms and predictors of hypertension and cardiovascular disease associated with VEGF receptor inh…
-
CLINICAL_TRIALS trial_result · 2024-01-10Clinical Trial Update: An Exploratory Study of Pembrolizumab Plus Entinostat in Non-Inflamed Stage III/IV Melanoma [Phase 2]
A Phase 2 exploratory trial evaluating pembrolizumab in combination with entinostat for non-inflamed stage III/IV melanoma has completed wit…
-
CLINICAL_TRIALS trial_result · 2024-01-05Clinical Trial Update: Encorafenib, Binimetinib and Palbociclib in BRAF-mutant Metastatic Melanoma CELEBRATE [Phase 1, Phase 2]
Clinical trial update exploring encorafenib, binimetinib, and palbociclib in BRAF-mutant metastatic melanoma across Phase 1 and Phase 2.
-
CLINICAL_TRIALS trial_result · 2023-12-22Clinical Trial Update: A Study to Evaluate Sotigalimab (APX005M) in Subjects With Unresectable or Metastatic Melanoma [Phase 2]
Phase 2 study evaluating sotigalimab (APX005M) in unresectable or metastatic melanoma has been terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2023-12-21Clinical Trial Update: Percutaneous Hepatic Perfusion in Patients With Hepatic-dominant Ocular Melanoma [Phase 3]
Phase 3 trial update for Percutaneous Hepatic Perfusion in hepatic-dominant ocular melanoma has completed.